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Abstract
Background: Recent studies have confirmed an association between bone metabolism and vascular homeostasis.
However, no study has examined the relationship between serum alkaline phosphatase (ALP) (a marker of bone
metabolism) and circulating immature cell such as CD34-positive cells (a marker of vascular homeostasis).
Methods: We conducted a cross-sectional study of this association in 272 elderly Japanese men (60–79 years).
Because low body mass index (BMI) status is a known characteristic of Japanese with a high incidence rate of
stroke, we used a stratified analysis based on BMI.
Results: Multivariable linear regression analysis adjusted for confounding factors showed a significant correlation
between serum ALP and the number of circulating CD34-positive cells, especially for participants with low BMI
(<23 kg/m2). The parameter estimates (β) and 95 % confidence intervals (CI) for one standard deviation increments
in serum ALP levels (62 IU/L) for the circulating CD34-positive cell count were β = 0.25 (0.04, 0.45) for total subjects,
β = 0.45 (0.16, 0.75) for participants with low BMI (<23 kg/m2), and β = 0.04 (−0.25, 0.34) for participants with high
BMI (≥23 kg/m2).
Conclusion: Serum ALP correlates positively with circulating CD34-positive cells among a general population of
elderly Japanese men, especially those with low BMI (<23 kg/m2). These findings suggest that serum ALP levels
may constitute an efficient tool for estimating the risk of insufficient vascular homeostasis, especially for participants
with relatively few classical cardiovascular risk factors.
Introduction
A previous study reported identifying a positive associ-
ation between elevated serum alkaline phosphatase
(ALP) and atherosclerosis [1]. Other prospective studies
have identified an association between high serum ALP
levels and mortality from all causes or cardiovascular
disease for subjects with previous myocardial infarction
[2] and previous stroke [3], in a clinic population [4], as
well as a general population [2]. However, in a retro-
spective study of ours as part of the Circulatory Risk in
Communities Study (CIRCS), we reported that not only
high but also low serum ALP levels may be a predictor
of risk of stroke for Japanese [5]. Other recent studies
reported detecting associations between bone metabol-
ism and vascular homeostasis [6–13] in view of the fact
that hematopoietic stem cells (immature cell such as
CD34-positive cell) derived from the bone marrow play
a major role in vascular homeostasis [7–9]. Because os-
teoblasts, whose activity can be evaluated in terms of
bone-type ALP expression [14, 15], regulate the produc-
tion of hematopoietic stem cells in the bone marrow
[10–12], serum ALP levels may be related to vascular
homeostatic activity. Another study reported that a re-
duction in the number of endothelial progenitor cells
(CD34-positive cells) is associated with an increase in
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the number of infarctions in patients with ischemic
stroke [16].
However, no study has examined whether the number
of circulating CD34-positive cells is associated with
serum ALP levels. In this connection, the prevalence of
obesity in adults defined by a body mass index (BMI) of
≥30 kg/m2 was only 3.6 % in Japan whereas it was
35.3 % in the USA in 2012 [17]. Nevertheless, the inci-
dence of stroke and stroke mortality is higher in East
Asian countries than in Western countries [18]. Since
only a study of a Japanese general population has identi-
fied a risk of stroke in association with lower serum ALP
level [5], the association between serum ALP level and
the number of circulating CD34-positive cells may be
strongly influenced by BMI status.
To investigate the validity of this hypothesis, we con-




Written consent forms were available in Japanese to en-
sure comprehensive understanding of the study objec-
tives, and informed consent was signed by all
participants. Since postmenopausal changes such as
osteopenia, osteoporosis [19], and dyslipidemia are
known to have a major impact on serum ALP levels,
women were not considered suitable subjects for an ana-
lysis of the association between serum ALP and circulat-
ing CD34-positive cells. The survey population
comprised 409 60–79-year-old men who underwent a
general medical check-up as recommended by the Japa-
nese government. They were residents of rural commu-
nities in the Goto Islands in western Japan and
participated in this study in 2013 and 2014.
Persons with missing data (n = 132) were excluded. To
avoid the effect of bone disorders such as osteoporosis,
bone fracture, and bone tumor, we also excluded persons
with a high serum ALP level (>400 IU/L) (n = 5). The
remaining 272 men with a mean age of 66.6 years
(standard deviation (SD) ±4.4; range 60–79), none of
whom were taking medication for anemia, were enrolled
in this study, which was approved by the Ethics Com-
mittee for Human Use of Nagasaki University (project
registration number 0501120073).
Data collection and laboratory measurements
Body weight and height were measured with an auto-
matic body composition analyzer (BF-220; Tanita,
Tokyo, Japan) when blood samples were obtained, and
BMI (kg/m2) was calculated. Systolic blood pressure and
diastolic blood pressure were recorded at rest.
Fasting blood samples were collected in a heparin so-
dium tube and a siliconized tube. Fresh samples (within
24 h from obtained) from the former were used for de-
termining the number of CD34-positive cells. BD (Beck-
ton Dickinson Biosciences) Trucount™ technology for an
accurate and reproducible single platform assay with
International Society of Hematotherapy and Graft En-
gineering (ISHAGE) guidelines [20, 21] which was sup-
ported by an automated software on the BD FACSCant™
II system was used to measuring circulating CD34-
positive cells. Serum samples were separated for the
measurement of concentrations of alkaline phosphatase
(ALP), aspartate aminotransferase (AST), serum alanine
aminotransferase (ALT), and γ-glutamyltranspeptidase
(γ-GTP) with the Japanese Society of Clinical Chemistry
(JSCC) standardization method.
Triglyceride (TG) and creatinine were measured with
the enzyme method. HDL-cholesterol (HDL), calcium
(Ca), and phosphorus (P) were measured by direct
method, Arsenazo III method, and molybdate direct
method, respectively. Hemoglobin A1c (HbA1c) was
measured with the latex coagulation method. The glom-
erular filtration rate (GFR) was estimated by means of
an established method with three variations recently
proposed by a working group of the Japanese Chronic
Kidney Disease initiative [22]. According to this adapted
version, GFR (mL/min/1.73 m2) = 194 × (serum creatin-
ine (enzyme method))−1.094 × (age)−0.287.
Statistical analysis
Characteristics of the study participants were expressed
in terms of BMI status.
Simple correlation analyses of serum ALP and other
variables affecting BMI status, as well as of the numbers
of CD34-positive cells and other variables, were per-
formed. Multiple linear regression analysis was per-
formed to determine the correlations between the
number of circulating CD34-positive cells and one SD
increment in ALP (62 IU/L). Because ALP is expressed
differently in various tissues, with notably high concen-
trations in the liver, bone, and kidneys [14], we designed
the analyses to allow for adjustments for classical cardio-
vascular risks factors and factors associated with the
liver, as well as factors that might be directly involved in
bone metabolism. The latter factors comprised age, sys-
tolic blood pressure (mmHg), diastolic blood pressure
(mmHg), body mass index, smoking status (never
smoker, former smoker, current smoker), alcohol con-
sumption (never drinker, former drinker, current drinker
[<23, 23–45, 46–68, ≥69 g/week]), HbA1c (%), HDL
(mg/dL), TG (mg/dL), AST (IU/L), ALT (IU/L), γ-GTP
(IU/L), Ca (mg/dL), P (mg/dL), and GFR (mL/min/
1.72 m2).
All statistical analyses were performed with the SAS
system for Windows (version 9.3; SAS Inc., Cary, NC).
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Probability values less than 0.05 were considered indica-
tive of statistical significance.
Results
Table 1 shows the characteristics of the study popula-
tion. Compared to participants with low BMI (defined as
<23 kg/m2), participants with high BMI (defined as
≥23 kg/m2) show significantly higher systolic blood pres-
sure, diastolic blood pressure, TG, ALT, γ-GTP, HbA1c,
and serum creatinine while significantly lower HDL and
GFR.
Simple correlation analysis was used to determine as-
sociations of serum ALP with other variables affecting
BMI status (Table 2). For total subjects, serum ALP cor-
related positively with age, TG, and AST and negatively
with HDL and alcohol consumption. Stratification of
those correlations by BMI status disclosed that ALP cor-
related with TG for both participants with low BMI and
high BMI. We also found that ALP correlated positively
with AST and γ-GTP and negatively with alcohol con-
sumption and HDL for high BMI and positively with age
for low BMI.
Simple correlation analyses of the number of circulating
CD34-positive cells and other variables are shown in
Table 3. The cells showed a significantly positive correlation
with serum ALP for total (r = 0.14, p = 0.020) and low BMI
(r= 0.29, p = 0.001) but not for high BMI (r = 0.04, p =
0.637). We also determined the correlation between
number of circulating CD34-positive cells and a one SD in-
crement in serum ALP (Fig. 1).
As shown in Table 4, multiple linear regression ana-
lysis adjustment for confounding factors showed that the
number of circulating CD34-positive cells correlated
positively with a one SD increment in serum ALP for
total (β = 0.25, p = 0.019) and low BMI (β = 0.45, p =
0.003) but not for high BMI (β = 0.04, p = 0.772).
Discussion
The major finding of this study of elderly Japanese men
was that serum ALP significantly and positively corre-
lates with circulating CD34-positive cells, especially for
participants with low BMI (<23 kg/m2). This suggests
that serum ALP levels may constitute an efficient tool
for estimating the risk of insufficient vascular homeosta-
sis, especially for participants with relatively few classical
cardiovascular risk factors.
The mechanism most likely to be responsible for the
association between serum ALP and circulating CD34-
positive cell is impaired vascular homeostasis since
hematopoietic stem cells derived from the bone marrow
play a major role in vascular homeostasis [7–9]. More-
over, because osteoblasts (whose activity can be assessed
in terms of bone-type ALP expression [14, 15]) regulate
the production of hematopoietic stem cells in the bone
marrow [10–12], serum ALP level may correlate with
vascular homeostatic activity, and a prospective study
Table 1 Age-adjusted characteristics of study population by BMI status
BMI <23 kg/m2 BMI ≥23 kg/m2 p value
No. of participants 122 150
Age, years 66.5 ± 4.4 66.7 ± 4.4
Circulating CD34-positive cells, cells/μL 1.33 1.55 0.231
Serum alkaline phosphatase (ALP), UI/L 239 225 0.065
Systolic blood pressure, mmHg 134 139 0.016
Diastolic blood pressure, mmHg 81 87 <0.001
Body mass index (BMI), kg/m2 20.9 25.7 <0.001
Current drinker, % 76.4 84.5 0.088
Current smoker, % 28.4 20.3 0.111
Serum HDL-cholesterol (HDL), mg/dL 61 54 <0.001
Serum triglycerides (TG), mg/dL 104 127 0.046
Hemoglobin A1c (HbA1c), % 5.6 5.8 0.027
Serum aspartate aminotransferase (AST), IU/L 24 26 0.105
Serum alanine aminotransferase (ALT), IU/L 20 26 <0.001
Serum γ-glutamyltranspeptidase (γ-GTP), IU/L 36 53 0.007
Serum calcium (Ca), mg/dL 9.3 9.3 0.208
Serum phosphorus (P), mg/dL 3.3 3.3 0.455
Serum creatinine, mg/dL 0.82 0.86 0.016
Glomerular filtration rate (GFR), mL/min/1.73 m2 75.1 71.2 0.023
Age: mean ± standard deviation
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Table 2 Simple correlation analysis of ALP and other variables
Total subjects BMI <23 kg/m2 BMI ≥23 kg/m2
r p r p r p
No. of participants 272 122 150
Age 0.16 0.010 0.22 0.017 0.11 0.165
Systolic blood pressure 0.11 0.072 0.10 0.287 0.16 0.056
Diastolic blood pressure 0.06 0.364 0.08 0.383 0.09 0.255
Body mass index (BMI) −0.08 0.190 −0.14 0.115 0.12 0.156
Alcohol consumption −0.20 <0.001 −0.13 0.149 −0.24 0.003
Smoking status 0.05 0.423 0.05 0.567 0.03 0.698
Serum HDL-cholesterol (HDL) −0.19 0.002 −0.13 0.140 −0.30 <0.001
Serum triglycerides (TG) 0.29 <0.001 0.24 0.008 0.36 <0.001
Hemoglobin A1c (HbA1c) 0.04 0.536 0.04 0.635 0.06 0.454
Serum aspartate aminotransferase (AST) 0.13 0.033 0.05 0.583 0.20 0.013
Serum alanine aminotransferase (ALT) 0.08 0.205 0.04 0.670 0.15 0.061
Serum γ-glutamyltranspeptidase (γ-GTP) 0.09 0.119 0.01 0.879 0.16 0.046
Serum creatinine −0.07 0.279 −0.12 0.190 0.002 0.980
Glomerular filtration rate (GFR) 0.07 0.263 0.09 0.306 −0.02 0.773
Serum calcium (Ca) −0.11 0.078 −0.12 0.175 −0.08 0.325
Serum phosphorus (P) −0.08 0.191 −0.10 0.266 −0.07 0.385
Alcohol consumption [never drinker, former drinker, current drinker (<23, 23–45, 46–68, ≥69 g/week)] and smoking status (never smoker, former smoker,
current smoker)
Table 3 Simple correlation analysis of number of circulating CD34-positive cells and other variables
Total subjects BMI <23 kg/m2 BMI ≥23 kg/m2
r p r p r p
No. of participants 272 122 150
Age −0.04 0.460 0.09 0.349 −0.15 0.072
Systolic blood pressure −0.04 0.503 −0.02 0.856 −0.08 0.309
Diastolic blood pressure −0.01 0.894 0.06 0.520 −0.09 0.250
Body mass index (BMI) 0.03 0.642 0.04 0.666 −0.10 0.202
Alcohol consumption −0.03 0.623 −0.04 0.652 −0.04 0.646
Smoking status −0.03 0.611 −0.002 0.983 −0.05 0.576
Serum HDL-cholesterol (HDL) −0.03 0.633 0.04 0.689 −0.06 0.466
Serum triglycerides (TG) 0.10 0.073 0.08 0.353 0.11 0.171
Hemoglobin A1c (HbA1c) 0.10 0.118 −0.02 0.829 0.18 0.028
Serum aspartate aminotransferase (AST) −0.05 0.490 −0.07 0.459 −0.04 0.631
Serum alanine aminotransferase (ALT) 0.05 0.419 −0.05 0.579 0.07 0.364
Serum γ-glutamyltranspeptidase (γ-GTP) 0.01 0.863 0.04 0.635 −0.02 0.837
Glomerular filtration rate (GFR) −0.03 0.616 −0.04 0.696 −0.01 0.902
Serum calcium (Ca) 0.002 0.978 −0.01 0.932 −0.001 0.989
Serum phosphorus (P) −0.04 0.563 −0.10 0.240 0.02 0.790
Serum alkaline phosphatase (ALP) 0.14 0.020 0.29 0.001 0.04 0.637
Alcohol consumption [never drinker, former drinker, current drinker (<23, 23–45, 46–68, ≥69 g/week)] and smoking status (never smoker, former smoker,
current smoker)
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reported a strong association between a reduced number
of endothelial progenitor cells (CD34-positive and KDR-
positive cell) and risk of cardiovascular disease [23]. Yet
another study found an association of a reduction in the
number of endothelial progenitor cells (CD34-positive
cells) with an increase in the number of infarctions
>5 mm in diameter, but no such association with athero-
sclerosis in carotid arteries of patients with ischemic
stroke [16]. Endothelial progenitor cells contribute to
vascular repair [24, 25], and a reduction in the number
of these cells may thus increase the risk of stroke. Re-
sults of another retrospective CIRCS study of ours indi-
cated that not only higher but also lower serum ALP
levels may be a predictor of the risk of stroke among
Japanese [5]. These findings seem to be, at least in part,
compatible with those of our present study.
Since hematopoietic stem cells have also been reported
to participate in the pathogenesis of atherosclerosis [13],
an increase in serum ALP may be associated with the
deterioration of arterial stiffness. A previous study re-
ported that, independent of other traditional cardiovas-
cular risk factors, elevated serum ALP is associated with
atherosclerosis evaluated by means of ankle-brachial
blood pressure index [1]. However, in our subsequent
analysis (n = 191), we could not find any association be-
tween serum ALP and arterial stiffness evaluated by
cardio-ankle vascular index (CAVI) (r = −0.02; P = 0.874).
Since our study population consists of elderly subjects
and side population hematopoietic bone marrow stem
cells diminish as individuals age [26, 27], so that even
vascular injury can activate bone marrow metabolism,
the bone marrow could not be activated as it would be
in younger participants while the atherosclerotic lesion
might have originated in their younger years. Further-
more, extensive reduction in bone marrow activity also
may have a confounding effect on the aforementioned
associations. The significant correlation between serum
ALP and circulating CD34-positive cells observed in our
study was therefore restricted to low BMI. In addition,
participants with high BMI possessed many more clas-
sical cardiovascular risk factors such as metabolic syn-
drome than did those with lower BMI (<23 kg/m2). In
this connection, the World Health Organization (WHO)
has identified BMI ≥23 kg/m2, which corresponds to the
median BMI in our study, as an indicator for enhanced
risk of disease for Asian populations [28]. Another
CD34 positive cell count = 0.21×(1SD increment in ALP) + 1.45
CD34 positive cell count = 0.41×(1SD increment in ALP) + 1.28




































































Fig. 1 Relationship between circulating CD34-positive cells and one SD increment in serum ALP in a total subjects, b those with low BMI
(<23 kg/m2), and c those with high BMI (≥23 kg/m2)
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possible mechanism that might explain why a significant
correlation between serum ALP and the number of cir-
culating CD34-positive cells is limited to low BMI
(<23 kg/m2) is the fact that the factors that determine
the serum ALP levels are different. Serum ALP is classi-
fied in terms of isoenzymes, that is, liver-type, bone-
type, and intestinal-type [29]. For the subjects with high
BMI in our study, serum ALP levels are much more
likely to be influenced by factors associated with liver
condition such as alcohol consumption, HDL, AST, and
γ-GTP than for the subjects with low BMI. Furthermore,
the simple correlation analyses showed significant corre-
lations between the number of circulating CD34-positive
cells and HbA1c for high BMI but not for low BMI
(≥23 kg/m2). Since HbA1c levels were significantly
higher for subjects with high BMI than for those with
low BMI, HbA1c could be an important stimulating fac-
tor for circulating CD34-positive cell production in sub-
jects with high BMI but not with low BMI.
Our findings should be interpreted with some caution.
First, because the ALP isoenzyme was not measured
[29], we could not assess which type of ALP correlated
with circulating CD34-positive cells. However, in the
present study, we detected a significant correlation be-
tween serum ALP and the circulating number of CD34-
positive cells. Second, because of the limited number
of participants, we could not perform a drinking
status-specific analysis even though serum ALP is
known to be associated with drinking status [5, 30].
However, a significant correlation between serum ALP
and circulating CD34-positive cells was observed even
after adjustment for alcohol consumption. Further-
more, the significant correlation between serum ALP
and alcohol consumption was observed only among
participants with high BMI.
Although the correlation between serum ALP levels
and circulating CD34-positive cells was shown to be
independent of the traditional risk factors, we did not
adjust for other potential confounding factors whose
values were associated with serum ALP, such as cal-
oric, protein, vitamin C, magnesium, and zinc defi-
ciencies [31].
In conclusion, we showed that serum ALP correlates
positively with circulating CD34-positive cells among a
general population of elderly Japanese men, especially
those with low BMI (<23 kg/m2). These findings suggest
that serum ALP levels may constitute an efficient tool
for estimating the risk of insufficient vascular homeosta-
sis, especially for participants with comparatively few
classical cardiovascular risk factors.
Table 4 Multiple linear regression analysis of circulating CD34-positive cells with relevant factors adjusted for confounding factors
Total subjects BMI <23 kg/m2 BMI ≥23 kg/m2
β 95 % CI p β 95 % CI p β 95 % CI p
No. of participants 272 122 150
Age −0.02 (−0.06, 0.03) 0.467 0.02 (−0.04, 0.09) 0.485 −0.07 (−014,
−0.004)
0.038
Systolic blood pressure −0.01 (−0.02, 0.01) 0.462 −0.02 (−0.04, 0.01) 0.175 0.005 (−0.02, 0.03) 0.671
Diastolic blood pressure −0.002 (−0.03, 0.02) 0.852 0.02 (−0.02, 0.06) 0.360 −0.02 (−0.06, 0.01) 0.152
Body mass index (BMI) 0.01 (−0.06, 0.09) 0.749 0.10 (−0.09, 0.29) 0.291 −0.11 (−0.25, 0.03) 0.134
Alcohol consumption 0.02 (−0.09, 0.13) 0.682 −0.02 (−0.19, 0.14) 0.770 −0.01 (−0.16, 0.14) 0.906
Smoking status −0.13 (−0.42, 0.16) 0.390 0.04 (−0.41, 0.48) 0.874 −0.31 (−0.72, 0.09) 0.129
Serum HDL-cholesterol (HDL) 0.01 (−0.01, 0.02) 0.400 0.02 (−0.005, 0.04) 0.138 −0.003 (−0.03, 0.02) 0.800




0.736 0.002 (−0.001, 0.01) 0.178
Hemoglobin A1c (HbA1c) 0.14 (−0.16, 0.44) 0.367 −0.09 (−0.55, 0.37) 0.704 0.44 (−0.01, 0.89) 0.056
Serum aspartate aminotransferase (AST) −0.03 (−0.06, 0.01) 0.104 −0.03 (−0.09, 0.02) 0.241 −0.03 (−0.07, 0.02) 0.252
Serum alanine aminotransferase (ALT) 0.02 (−0.01, 0.04) 0.250 0.01 (−0.04, 0.06) 0.767 0.01 (−0.02, 0.05) 0.387
Serum γ-glutamyltranspeptidase (γ-GTP) 0.001 (−0.004,
0.005)
0.821 0.004 (−0.01, 0.02) 0.468 0.001 (−0.004, 0.01) 0.701
Glomerular filtration rate (GFR) −0.004 (−0.02, 0.01) 0.571 −0.004 (−0.02, 0.02) 0.703 −0.003 (−0.02, 0.02) 0.775
Serum calcium (Ca) 0.01 (−0.56, 0.58) 0.970 0.06 (−0.82, 0.94) 0.889 −0.11 (−0.88, 0.66) 0.776
Serum phosphorus (P) −0.13 (−0.56, 0.31) 0.565 −0.06 (−0.76, 0.63) 0.854 0.05 (−0.56, 0.65) 0.880
One SD increment in serum alkaline phosphatase
(ALP)
0.25 (0.04, 0.45) 0.019 0.45 (0.16, 0.75) 0.003 0.04 (−0.25, 0.34) 0.772
Alcohol consumption [never drinker, former drinker, current drinker (<23, 23–45, 46–68, ≥69 g/week)] and smoking status (never smoker, former smoker,
current smoker)
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